BioCellara
Resources
Research and regulatory
resources
BioCellara curates official guidance and peer-reviewed research to
help providers and patients distinguish product information, biological
mechanisms, clinical evidence, and regulatory status. External resources
are provided for education; inclusion does not constitute endorsement of
a product or use.
Stem cells and
regenerative medicine
- NIH Stem
Cell Basics — foundational definitions and stem-cell biology. - What
Are Stem Cells? — NIGMS — plain-language overview from an NIH
institute. - FDA
Consumer Alert on Regenerative Medicine Products — patient safety
and approval-status information. - ISSCR
Patient Guide — questions and considerations for evaluating
stem-cell treatments. - ClinicalTrials.gov
search guidance — how to find and interpret registered clinical
studies.
Human tissue
allografts and extracellular matrix
- 21
CFR Part 1271 — federal HCT/P regulations. - 21
CFR Part 1271, Subpart C — donor-eligibility requirements. - FDA
guidance on minimal manipulation and homologous use — FDA’s current
thinking on key HCT/P criteria. - Extracellular
matrix as a biological scaffold material — peer-reviewed overview of
ECM scaffold structure and function. - CTM Biomedical
product information — official product families and
configurations.
Exosomes and extracellular
vesicles
- FDA
Public Safety Notification on Exosome Products — FDA approval and
safety information. - FDA
Consumer Alert — consumer guidance on stem-cell and exosome
products. - Platinum Biologics
research page — supplier-provided research and product-status
information.
Peptides and compounding
- Compounding
and the FDA: Questions and Answers — distinction between approved
and compounded drugs. - FDA
information for consumers and healthcare professionals — risks and
quality considerations. - FDA
safety information for certain bulk substances — substance-specific
safety concerns. - Therapeutic
peptides: historical perspectives and future directions —
peer-reviewed overview. - Therapeutic
peptides: current applications and future directions — open-access
review.
Red light and
photobiomodulation
- Mechanisms and
efficacy of photobiomodulation therapy — review of proposed
mechanisms and evidence. - Photobiomodulation—underlying
mechanism and clinical applications — open-access scientific
review. - Photobiomodulation CME
Part I: overview and mechanism — 2024 clinical overview. - Clinical
applications of low-level light therapy — review of clinical
literature and commercialization context.